ArticleEuropean journal of clinical pharmacology2022

Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.

Emre Yekedüz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.